Stay updated on Pembrolizumab Combo in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    An NIH-wide notice about the terminology transition appears above the 403 error page. The site revision label also advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:10:37.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.1 instead of v3.7.0. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T01:14:41.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, with a minimal header and a Home link indicating restricted access. This reflects an access restriction rather than a substantive data update.
    Difference
    25%
    Check dated 2026-09-23T01:13:00.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.6 to v3.7.0 on the page, indicating an update to the site's template or CMS without changing the study details.
    Difference
    0.0%
    Check dated 2026-09-16T00:16:15.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a new revision of the page rather than a change in substantive content.
    Difference
    0.0%
    Check dated 2026-09-01T19:38:02.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, indicating a minor deployment update. No study content or data are altered.
    Difference
    0.0%
    Check dated 2026-08-11T19:16:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Lung Cancer Clinical Trial page.